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INSTRUCTIONAL DESIGN AND ASSESSMENT
Analysis of Compounded Pharmaceutical Products to Teach the
Importance of Quality in an Applied Pharmaceutics Laboratory Course
Alyssa Pignato, BS, PharmD Candidate, and Christine R. Birnie, PhD
Wegmans School of Pharmacy, St. John Fisher College, Rochester, New York
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Objective. To assess the effectiveness of a product-analysis laboratory exercise in teaching students
the importance of quality in pharmaceutical compounding.
Design. Second-year pharmacy students (N577) participated in a pharmaceutical compounding lab-
oratory exercise and subsequently analyzed their final product using ultraviolet (UV) spectrometry.
Assessment. Reflection, survey instruments, and quiz questions were used to measure how well
students understood the importance of quality in their compounded products. Product analysis showed
that preparations compounded by students had an error range of 0.6% to 140%, with an average error of
23.7%. Students’ reflections cited common sources of error, including inaccurate weighing, contam-
ination, and product loss during both the compounding procedure and preparation of the sample for
analysis. Ninety percent of students agreed that the exercise improved their understanding of the
importance of quality in compounded pharmaceutical products. Most students (85.7%) reported that
this exercise inspired them to be more diligent in their preparation of compounded products in their
future careers.
Conclusion. Integrating an analytical assessment during a pharmaceutical compounding laboratory
can enhance students’ understanding of quality of compounded pharmaceutical products. It can also
provide students a chance to reflect on sources of error to improve their compounding technique in
the future.
Keywords: compounding, analysis, pharmaceutics, pharmacy practice laboratory
INTRODUCTION
As the number of patient-specific medicinal thera-
pies increases, pharmaceutical compounding remains
a pertinent skill for pharmacists to master. According to
the InternationalAcademyofCompounding Pharmacists,
compounded prescriptions comprise approximately 1%
to 3% of the United States’ prescription market.1 Com-
pounding is especially useful for targeting patients who
are challenging to treat; specifically pediatric, geriatric,
and veterinary patients.2 Additionally, compounding en-
ables patients to regain access to medications removed
from the market because of manufacturer cost burden.
Medical professionals and patients rely on pharmacists to
compound these products using the highest-quality stan-
dards, which are thoroughly outlined in the United States
Pharmacopeia/National Formulary (USP/NF), the official
compendia of the United States.2 In an effort to ensure
compounding pharmacies are fulfilling these guidelines,
the Pharmacy Compounding Accreditation Board was
founded. This organization provides a standardized system
for evaluating and validating quality-control techniques
performed by compounding pharmacies voluntarily seek-
ing accreditation.3 Even though resources are available to
compounders, errors that have the potential to compromise
patient safety still occur. The Federal DrugAdministration
(FDA) performed a limited survey in 2001 in which com-
pounded products from 12 pharmacies across the United
States were evaluated using standard quality testing out-
lined by the USP. Of the 29 samples evaluated for potency
testing, 9 (31%) of the products failed, with concentrations
ranging from 59% to 89% of the label claim.4 In a subse-
quent 2006 FDA survey, 36 samples from various com-
pounding pharmacies were analyzed for potency of bulk
active pharmaceutical ingredient (API) and products con-
taining that active ingredient were compounded. All bulk
API samples contained the label claim based on assay re-
sults; however, 33% of the compounded products failed
potency testing, with drug concentrations ranging from
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67.5% to 268.4% of label claim.5 Although these studies
had small sample sizes and significant limitations, their
results raised valid concerns regarding the quality of com-
pounded products being dispensed. High-profile com-
pounding errors publicized in the media have revealed
the tragic consequences of improper compounding.6,7
With the recent compounding errors resulting in numerous
deaths from contaminated methylprednisolone acetate
steroid injections, and the subsequent Drug Quality and
Security Act being proposed into legislation, the impor-
tance of pharmacists practicing proper quality-assurance
procedures has heightened awareness.8-12 The foundation
for accurate compounding must begin at the pharmacy-
education level and resonate with pharmacy students,
empowering them to be more cognizant of the proper
quality-control procedures and tomaintain these high stan-
dards throughout their pharmacy careers.
The Accreditation Council of Pharmacy Education
Standards requires students to learn the “techniques and
principles used to prepare and dispense individual extem-
poraneous prescriptions.”13 This topic is also addressed
by the Center for Advancement of Pharmaceutical Edu-
cation Outcomes, which maintains that students must
“prepare safe and effective dosage forms and perform
in-process quality control.”14 To fulfill these requirements,
pharmacy colleges and schools have full authority regard-
ing the extent of compounding instruction included in the
curriculumand themeans bywhich students are evaluated
for “quality control.” The boards of pharmacy in Georgia
and New York, for example, place a greater emphasis on
the art of compounding and require successful completion
of a hands-on (wet laboratory) compounding examination
for licensure. Both state boards of pharmacy evaluate
students based on correctness of calculations, procedure,
labeling, visual inspection, and scalar measurements (eg,
weight, volume) but do not require analytical testing of
the product (A.T. Corigliano, e-mail, January 21, 2013;
T.F. Allen, e-mail, November 5, 2012). Interestingly, no
state requires students to provide proof that they are able
to compound products that fulfill USP standards with re-
spect to potency and purity.15-17 It is therefore imperative
for pharmacy colleges and schools to take initiative to
verify that students are preparing pharmaceutically ele-
gant products that fulfill the USP quality standards test-
ing. This goal can be accomplished by incorporating an
analytical method in the compounding laboratory.
A survey evaluating the compounding curriculum
within pharmacy colleges and schools identified the lack
of analytical testing in educational compounding labora-
tories. Most survey respondents cited direct observation
as their primary assessment approach, while only a small
percentage (8%) of institutions used a quantitative method
to evaluate student preparations.18 Although this studywas
not all-inclusive, it did reflect a trend among pharmacy
colleges and schools in the assessment of students’ com-
pounded products. Other concerns identified in the liter-
ature include students’ retention of compounding skills
and the attenuated role of compounding in academia.19,20
Some institutions have attempted to implement analytical
testing in the laboratory through changes in course design
and assessment.21-27 One study in which the accuracy of
pharmaceutical products compounded by pharmacy stu-
dents was evaluated found that 54% of students prepared
the desired potassium permanganate solution within 10%
of the intended concentration.27 Students who were un-
successful in accurately compounding the solution had
concentrations ranging from less than 75% to greater than
200%. In the same study, 78% of student preparations of
caffeine citrate solution fell within 10% of the intended
concentration, with errors ranging from less than 89% to
more than 269% of the required potency. The wide vari-
ation in product potency compounded by pharmacy stu-
dents mirrors the FDA’s findings on a national level.
Incorporating analytical testing of compounded phar-
maceutical products into the pharmacy curriculum gives
students a sense of accountability for ensuring that their
products meet the acceptable quality standards to dispense
to a patient. This study describes the design and implemen-
tation of a product-analysis laboratory to teach students the
importance of quality in compounded products. The labo-
ratory included preparation of a compounded product, sub-
sequent analytical testing, product evaluation, and student
reflection. The impact of the exercise on students’ percep-
tions regarding the importance of quality in compounding
was also recorded.
DESIGN
Beginning in the first year of a 4-year doctor of
pharmacy (PharmD) program at St. John Fisher College,
Wegmans School of Pharmacy, students were taught
foundational principles of physical, chemical, and bio-
logical mechanisms involved in drug formulation during
the pharmaceutics course sequence. Students were ex-
pected to use this knowledge in a practical setting as part
of a 2-semester Applied Pharmaceutics compounding lab-
oratory sequence, comprising 2 single-credit-hour courses
offered during the second year. The courses consisted of
a 1-hour prelaboratory lecture in conjunctionwith a 3-hour
laboratory period consisting of 2 sections. Course evalua-
tion comprised of 2 practicals, a cumulative final labora-
tory practical, 2 quizzes, and an overall professionalism
score. Final products were assessed by visual inspection,
accuracy of calculations, and completeness of compound-
ing procedure. Individual laboratory sessions were not
American Journal of Pharmaceutical Education 2014; 78 (3) Article 61.
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graded in order to provide students the opportunity to
refine their compounding skills and learn from their errors
in a controlled learningenvironment.Course instructors and
teaching assistantswere available consistently throughout
the laboratory sessions to provide feedback and answer
students’ questions. Faculty members rotated teaching
throughout the semester to provide instructional guidance
on their particular dosage-form specialty.
The product-analysis exercise was incorporated dur-
ing the second-semester laboratory course. At the com-
pletion of this laboratory session students were expected
to (1) prepare a compounded product with a designated
level of precision and accuracy; (2) complete a pharma-
ceutical analysis of a compounded product; (3) accurately
perform calculations related to compounding and dilu-
tion; (4) identify sources of error that could have occurred
in pharmaceutical compounding and analysis; (5) eval-
uate assay results of a compounded product to determine
if it met the quality standards necessary to dispense for
patient use; and (6) comprehend the importance of accu-
racy and quality in compounded products. These learning
outcomes and the corresponding instruments used to
assess them are presented in Table 1. The St. John Fisher
College Institutional Review Board approved this pro-
ject as exempt.
Students were provided a packet containing a pre-
scription for methimazole 5% in poloxamer lecithin
organogel (PLO), directions for compounding, assay
procedure, and reflection questions during the 1-hour
prelaboratory class session held 1 week prior to the labo-
ratory exercise. 28,29 (Appendix 1). Studentswere informed
that they would assay their final product to determine po-
tency using UV spectroscopy. Supplying the materials
prior to the exercise gave students sufficient time to com-
plete the calculations and familiarize themselves with the
product in anticipation of the analytical process. Students
were also informed that a bonus point would be added to
their next quiz if their product analysis was found to be
within an acceptable range.
During the 3-hour laboratory period, students com-
pounded the prescription according to the instructions
provided and removed a 0.5-gram sample for the assay.
This sample was serially diluted and filtered before being
placed in a plastic cuvette and assayed using the UV spec-
trophotometer at a wavelength of 252 nm. With the ab-
sorbance value obtained from the UV spectrophotometer,
students calculated the concentration of the sample de-
rived from the product they prepared.
After conducting the assay, students were asked to
complete the last page of their laboratory exercise, in-
cluding a calculationworksheet with reflection questions.
Students were instructed to use the Beer-Lambert Law
equation to convert their absorbance value to concentra-
tion, perform calculations to determine the concentration
of assayed solution after performing serial dilutions, and
calculate a percentage of error based on their product ver-
sus the target concentration. The reflection portion of the
exercise required students to evaluate their assay results by
indicating whether their product met an appropriate level
of quality required to dispense to their patients. Students
were also provided an opportunity to reflect on poten-
tial sources of error in their compounding or analytical
procedure.
As per standard procedure for the semester labora-
tory, each student then completed a final “check-out”with
a teaching assistant or laboratory instructor to review the
prescriptionwrite-ups, final products, analysisworksheet,
and reflection questions. The teaching assistant/instructor
ensured that all aspects of the laboratory were completed,
during which time the student also had an opportunity to
ask any additional questions before leaving the laboratory.
EVALUATION AND ASSESSMENT
Students’ product analysis worksheets were collected
and tabulated at the conclusion of the laboratory exercise.
Absorbance values were used to determine the final con-
centration and percentage error for each sample. Of the
77 student products assayed, products ranged in errors from
0.6% to 140%, with an average error of 23.7%. Only
32 (41.6 %) products prepared by students fell within an
acceptable 10% error range. An additional 16 (20.8%)
samples fell within the 10% to 20% error range, with the
remaining 38% having an error rate of more than 20%.
Written responses identifying sources of errors were
coded to reveal common themes (Table 2). For a response
to be considered a theme, a minimum of 25% of students
had to have commented on that specific category. Over
72% of students discussed some form of measurement
error as a potential source of deviation from the expected
potency. Examples of these errors included improper cal-
ibration of balance, measuring more API than required,
andmeasuring an inappropriate amount of gel for the anal-
ysis portion. A second theme that more than 61% of stu-
dents cited involved errors made during the serial dilution
process. Many students commented that loss of product
could have occurred during the stepwise serial dilution or
as a result of inadequate dissolution of the product into the
assay solvent. Contamination of either the drug source or
glassware, including the plastic cuvette, was discussed by
over 25% of students. Twenty-five percent of students
reported that their errormay have occurred during the com-
pounding of the gel product. Students mentioned improper
mixing, loss of product while removing air bubbles, and
calculation errors as potential sources of inaccuracy.
American Journal of Pharmaceutical Education 2014; 78 (3) Article 61.
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When students were asked to reflect onwhether their
product was suitable for dispensing based upon the anal-
ysis results, a majority (97%) identified less than 10%
error as acceptable for dispensing. The remaining 3%
indicated an acceptable error of less than 5% and eval-
uated their results based on this guideline. As part of a
10-question laboratory quiz in the overall course assess-
ment, 2 questions pertained to the analysis laboratory.
The first was a calculation, similar to that required for the
dilution conducted in the laboratory. Of the 75 students
who completed the quiz, 56 (75.7%) responded correctly
to the open-ended question. The second question asked
students to explain why accuracy and quality of com-
pounded products is an important aspect of pharmaceu-
tical compounding. Of the 75 students who responded,
100% provided a correct written response, citing either
patient safety or medication effectiveness.
To obtain each student’s perspective on the labora-
tory, an optional 8-item questionnaire was distributed to
students at the end of the laboratory period. The volun-
tary survey instrument included 7 Likert-scale questions
and 1 open-ended question. Students were instructed to
Table 1. Learning Outcomes and Methods for Assessment in a Laboratory Exercise on Pharmaceutical Compounding
Learning Outcomes
Method of Assessing
Learning Outcome Questionnaire Statements
Learning
(Bloom’s Taxonomy)
Prepare compounded products
with a level of precision
and accuracy.
Product assay As a result of analyzing my own
compounded products in this lab,
I believe I will prepare
compounded products more
accurately in the future.
Application
Complete a pharmaceutical
analysis on a compounded
product.
Successful completion of
laboratory exercise as
documented by laboratory
instructor and teaching
assistants
As a result of this laboratory
exercise, I now know how
pharmaceutical products can
be analyzed for drug content.
Knowledge/
application
Accurately perform calculations
related to compounding
and dilution
Calculations recorded
on laboratory worksheet
and assessed by teaching
assistants and instructor
By performing the calculations
associated with this laboratory
exercise, I now feel more
confident about performing
calculations related to
compounding.
Application
Calculation question
on course quiz
Identify sources of error that can
occur in pharmaceutical
compounding and analysis.
Reflection question: What
sources of error may have
occurred in the preparation
or analysis of the product?
This laboratory experience helped
me to think through the sources
of error that may occur while
compounding and analyzing
compounded products.
Synthesis
I believe I know where the errors
associated with my compounded
product may have occurred.
Synthesis
Evaluate assay results of a
compounded product to
determine if it meets the
quality standards necessary to
dispense to a patient.
Reflection question: What is
the percent error of this
product? Based on your
analysis, is the product
suitable to dispense to a
patient?
After completing this laboratory,
I am more confident in my ability
to evaluate the assay results of
a compounded product.
Evaluation
Comprehend the importance
of accuracy and quality in
compounded products
Open-ended questions
on course quiz
The laboratory exercise involving
the assay of the methimazole
in PLO gel compounded product
I prepared helped me to better
understand the importance of
quality in compounding
pharmaceutical products.
Comprehension
Abbreviation: PLO5poloxamer lecithin organogel.
American Journal of Pharmaceutical Education 2014; 78 (3) Article 61.
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complete the survey instrument without any personal iden-
tifiers to maintain anonymity and to rank their level of
agreement with the statements using a 5-point Likert scale
(15strongly disagree, 25disagree, 35neutral, 45agree
and 55strongly agree) (Appendix 1). The survey instru-
ment questions were designed to match the learning out-
comes for the laboratory exercise (Table 1).
Of the 77 second-year pharmacy students who suc-
cessfully completed the product-analysis laboratory,
71 (92.2%) completed the survey instrument and returned
it at the conclusion of the laboratory exercise. The results
were reported using descriptive statistics (Table 3). The
students responded positively to all 7 questions, indicating
that the laboratory exercises were useful in emphasizing
the importance of quality in compounded products. Ninety
percent (63 of 70) of students agreedor strongly agreed that
the exercise helped them understand the importance of
quality in compoundingpharmaceutical products. Students
were also asked an open-ended question to allow them to
reflect on any future changes they would make to their
compounding technique based on their experience during
the exercise. Several responses emphasized taking more
care while compounding, cleaning glassware thoroughly
prior to compounding, and minimizing product loss while
measuring and mixing ingredients.
DISCUSSION
Pharmaceutical compounding offers a unique niche
in the healthcare arena. It not only provides patients with
Table 2. Summary of Themes in Student Reflection in
a Laboratory Exercise on Pharmaceutical Compounding:
Potential Sources of Error (N568)
Theme No. (%)
Errors due to inaccurate weighing
or measuring of volume
49 (72.1)
Errors involved during serial dilution 42 (61.8)
Errors due to contamination of drug
product, glassware, cuvette
20 (29.4)
Errors involved in compounding procedure 19 (27.9)
Table 3. Student Responses to a Survey Regarding Evaluation of Methimazole in PLO Gel Product in a Laboratory Exercise on
Pharmaceutical Compounding
Survey Instrument Question
Strongly
Disagree,
No. (%)
Disagree,
No. (%)
Neutral,
No. (%)
Agree,
No. (%)
Strongly
Agree,
No. (%)
No
Response,
No.
Mean
(SD)
The laboratory exercise involving the assay of
the methimzaole in PLO gel compounded
product I prepared helped me to better
understand the importance of quality in
compounding pharmaceutical products.
0 1 (1.4) 6 (8.6) 31 (44.3) 32 (45.7) 1 4.3 (0.7)
As a result of this laboratory exercise, I now
know how pharmaceutical products can be
analyzed for drug content.
0 2 (2.8) 8 (11.3) 33 (46.5) 28 (39.4) 0 4.2 (0.8)
This laboratory experience helped me to think
through the sources of error that may occur
while compounding and analyzing
compounded products.
0 1 (1.4) 6 (8.6) 39 (55.7) 24 (34.3) 1 4.2 (0.7)
I believe I know where the errors associated
with my compounded product may
have occurred.
1 (1.4) 3 (4.2) 13 (18.3) 34 (47.9) 20 (28.2) 0 4.0 (0.9)
By performing the calculations associated
with this laboratory exercise, I now feel
more confident about performing
calculations related to compounding.
0 2 (2.8) 10 (14.0) 37 (52.1) 22 (31.0) 0 4.1 (0.8)
After completing this laboratory, I am more
confident in my ability to evaluate assay
results of a compounded product.
0 2 (2.8) 15 (21.1) 32 (45.1) 22 (31.0) 0 4.0 (0.8)
As a result of analyzing my own compounded
products in this lab, I believe I will prepare
compounded products more accurately
in the future.
0 2 (2.9) 8 (11.4) 36 (51.4) 24 (34.3) 1 4.2 (0.7)
Abbreviations: PLO5poloxamer lecithin organogel.
American Journal of Pharmaceutical Education 2014; 78 (3) Article 61.
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drug formulations specifically tailored to best suit their
needs but also can improve patient compliance and health
outcomes. Unfortunately, compounding errors can have
deleterious effects that overshadow these benefits and
have a lasting impact on the pharmacy profession. It is
paramount that pharmacy students realize the responsi-
bility they have to their patients concerning quality of
compounded products. One mechanism of executing this
academically would be to incorporate an analytical ele-
ment to the compounding curriculum.
After compiling the students’ overall error percent-
ages, only 32 (41.6 %) products were found to be within
an acceptable 10% error rate. Error percentages ranged
from 0.6% to greater than 140%. This wide range in po-
tencymirrors similar trends seen by the FDAand reported
by other academic institutions.4,5,23,27 Several factors
may have contributed to the students’ poor analytical per-
formance. Although students were provided a bonus-
point incentive, their grade was not greatly affected by
the outcome of the product analysis. This may have in-
fluenced some students not to put forth their best effort
during the exercise. Also, the unique compounding pro-
cedure for this product is more complex than other dosage
forms, such as solutions or intravenous admixtures that
can be easily assayed. This laboratory exercise was pur-
posely designed to include analysis of a complex formu-
lation toward the end of the compounding course as
a means of a near-final assessment for the students. Anal-
ysis of a simpler formulation would have likely increased
the percentage of products that would have been deemed
acceptable for dispensing. Additionally, the assay sample
preparation required a 2-step dilution in volumetrics. This
multiple-step process had the potential to precipitate
product loss or contamination when conducted by a stu-
dent with limited analysis training.
After coding students’ reflection responses, many
students cited similar rationales for not obtaining a sample
within an acceptable potency range.Most of the responses
involved errors in measurement, measuring either too lit-
tle or too much active ingredient. Because this laboratory
took place near the end of the compounding sequence, it
was expected that students would be proficient in basic
tasks, such as accurate measuring. With the analysis hav-
ing no impact on the students’ grade, less care may have
been taken during the measurement process. A similar
study determined that student performance significantly
improved when students were required to remake unac-
ceptable products outside of their scheduled laboratory
time.23 This step may be a valid consideration for future
years in an effort to prompt students to use class time
meaningfully. Students mentioned that the multiple steps
involved for both the compounding and assay preparation
created many opportunities for product loss. This partic-
ular laboratory procedure incorporated a novel method
for mixing involving 2 syringes attached by a connector
as the mixing vessel. Students had never been exposed to
this type of compoundingmethod andmay have produced
better products if had theyfirstmastered the compounding
technique. Overall, having students identify their sources
of error was an important learning outcome to ensure they
could target their weaknesses and correct these errors in
subsequent attempts.
Students responded positively on survey items re-
garding the analytical laboratory component, agreeing
that this exercise enhanced their understanding of the
importance of quality compounded products and would
enable them to better prepare accurate products in the
future. A similar trend in student response was observed
in previous research involving pharmaceutical laboratory
analysis. 24 Most students were able to identify where
their errors may have occurred while compounding and
responded favorably to the exercise, with increased con-
fidence in compounding-related calculations. An impor-
tant aspect was the students’ ability to identify whether
the product was within an acceptable range for dispens-
ing. According to the survey, most students felt better
prepared to evaluate their product quality because of the
exercise.
This study has several limitations. The laboratory
handouts guided students through both the compounding
and analytical procedures. Providing students with only
the prescription and no other instructional material would
simulate a more realistic scenario in which pharmacy
students must take initiative to consult the appropriate
compounding monograph as a resource. Students were
also aware prior to the laboratory that the products were
to be assayed. Blinding students to the analysis portion
may have achieved different results and potentially a
greater impact for students regarding their skill level and
the care with which they compounded products. Other in-
stitutions might consider implementing an analytical lab-
oratory multiple times throughout the semester to provide
a longitudinal method for tracking student progress, taking
into account the potential cost and time implications. Be-
cause this laboratory exercise was a single assessment of
students’ ability to prepare quality compounded products,
it is unclear whether these attitudes or compounding abil-
ities were maintained beyond this laboratory exercise.
Measuring student perceptions by means of a preexercise
and postexercise survey instrument might provide a better
indication of students’ evolution of learning after exposure
to an analytical method. Regardless of methodology, phar-
macy colleges and schools must design pedagogy that will
ensure students’ understandingof the importanceofquality
American Journal of Pharmaceutical Education 2014; 78 (3) Article 61.
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in compounded products. Analytical testing of student
products combined with subsequent reflection appears to
be one way to accomplish this outcome.
From an institutional perspective, implementing an
analytical element to a laboratory can be an expensive and
time-consuming undertaking. Institutions might consider
collaborating with other departments in the college or
university for assays requiringmore advanced instrumen-
tation. For the purposes of this study, the UV spectropho-
tometer and bulk materials were relatively inexpensive
and already on hand at the institution. Additionally, using
assays developed from previous research at the institution
may provide an easier transition for classroom implemen-
tation. For example, extensive research was previously
performed at the Wegmans School of Pharmacy using
methimazole in PLO, facilitating the development of
the UV assay method and stability of the formulation.29
Faculty members were familiar with this product and
comfortable applying these methods on a larger scale
for classroom purposes.
The overarching theme of this laboratory exercise
was the importance of quality in compounding. All stu-
dents enrolled in the course completed an analytical assay
and accurately interpreted whether their product was ap-
propriate for dispensing to a patient. Every student effec-
tively identified sources of errors and performed the
calculations necessary for compounding and completing
the assay. The open-ended quiz question on the survey
instrument solidified that students understood that quality
is important for patient safety and medication effective-
ness. Student questionnaires correlated students’ percep-
tions regarding the measured outcomes. Although some
students were unable to accurately prepare this com-
pounded product within the recommended error range,
the impact the exercise had on all participants may have
been an equally important learning outcome. The exercise
caused them to look beyond the pharmaceutically elegant
products they had often prepared to evaluate the products
for drug content. This important aspect of quality in com-
pounded products is often marginalized by product ap-
pearance and elegance. The result of such negligence can
potentially be fatal to patients and, thus, should be a mo-
tivation for educational institutions to consider the addi-
tion of analytical methodology in their compounding
laboratories.
SUMMARY
Implementing product analysis in the pharmacy-
compounding curriculum provided students with the
opportunity to assess objectively their products for accu-
racy. Students were receptive to this laboratory exercise
and able to identify potential sources of error during their
compounding process. This assessment effectively en-
abled students to reflect on their compounding skills, un-
derstand the importance of compounding quality, and
better prepare to compound products more accurately in
their future careers.
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Appendix 1.Materials Distributed to Students During the Laboratory Session: (a)Methimazole 0.5% in PLOProcedure; (b) Analysis
Procedure for Methimazole 0.5% in PLO; (c) Evaluation of Methimazole in PLO Gel Product Evaluation
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